A new digital service for Marketing Authorisation Holders to submit pharmacovigilance reports to the VMD is now available.
A new digital service for Marketing Authorisation Holders (MAHs) of animal medicines to submit pharmacovigilance reports to the Veterinary Medicines Directorate (VMD) went live on 10 July 2026.
This follows the launch of our Adverse Event Reporting Service for use by animal owners, veterinary professionals and Suitably Qualified Persons on 20 May 2026.
The VMD Industry Pharmacovigilance Reporting Service brings together a range of submission types into a single platform, including Benefit-Risk Submission Reports, Pharmacovigilance Sales Submissions, dose factor justifications, signal notifications and XML reports.
Helping industry achieve pharmacovigilance compliance
The service has been designed to make it easier for MAHs to fulfil their legislative requirements, offering a more efficient and user-friendly experience than previous reporting routes. Key features include submission status tracking, exportable logs, in-system validation, and the option to submit digital forms for Benefit-Risk Submission Reports and signal notifications. A built-in product dictionary allows straightforward visualisation and selection of product groups and related product information.
Your feedback is needed
The service is being released as an optional beta version, and MAHs are encouraged to use the feedback function within the service to share their experience. The VMD will use this feedback to make further improvements, with additional functionality already planned for rollout over the next year.
MAHs who prefer to continue using the VMDS secure messaging service to submit reports may do so.
How to access the new service
To register for the new service head to: Report pharmacovigilance data for veterinary medicines